| Cost-effectiveness of heart failure therapies LE Rohde, EG Bertoldi, L Goldraich, CA Polanczyk Nature Reviews Cardiology 10 (6), 338-354, 2013 | 103 | 2013 |
| The Brazilian Cardioprotective Nutritional Program to reduce events and risk factors in secondary prevention for cardiovascular disease: study protocol (The BALANCE Program Trial) B Weber, ÂC Bersch-Ferreira, CR Torreglosa, MB Ross-Fernandes, ... American Heart Journal 171 (1), 73-81. e2, 2016 | 57 | 2016 |
| Short-term diuretic withdrawal in stable outpatients with mild heart failure and no fluid retention receiving optimal therapy: a double-blind, multicentre, randomized trial LE Rohde, MM Rover, JA Figueiredo Neto, LC Danzmann, EG Bertoldi, ... European Heart Journal 40 (44), 3605-3612, 2019 | 48 | 2019 |
| Cost-effectiveness of cardiac resynchronization therapy in patients with heart failure: the perspective of a middle-income country's public health system EG Bertoldi, LE Rohde, LI Zimerman, M Pimentel, CA Polanczyk International Journal of Cardiology 163 (3), 309-315, 2013 | 43 | 2013 |
| Mortality reduction of cardiac resynchronization and implantable cardioverter-defibrillator therapy in heart failure: an updated meta-analysis. Does recent evidence change the … EG Bertoldi, CA Polanczyk, V Cunha, PÍK Ziegelmann, L Beck-da-Silva, ... Journal of Cardiac Failure 17 (10), 860-866, 2011 | 38 | 2011 |
| Implementation of a Brazilian Cardioprotective Nutritional (BALANCE) Program for improvement on quality of diet and secondary prevention of cardiovascular events: A randomized … B Weber, ÂC Bersch-Ferreira, CR Torreglosa, A Marcadenti, ES Lara, ... American heart journal 215, 187-197, 2019 | 37 | 2019 |
| Long‐term cost‐effectiveness of diagnostic tests for assessing stable chest pain: modeled analysis of anatomical and functional strategies EG Bertoldi, SF Stella, LE Rohde, CA Polanczyk Clinical cardiology 39 (5), 249-256, 2016 | 27 | 2016 |
| Cost-effectiveness of anatomical and functional test strategies for stable chest pain: public health perspective from a middle-income country EG Bertoldi, SF Stella, LEP Rohde, CA Polanczyk BMJ open 7 (4), e012652, 2017 | 25 | 2017 |
| Clinical use of ultrasensitive cardiac troponin I assay in intermediate-and high-risk surgery patients FK Borges, MV Furtado, APW Rossini, C Bertoluci, VL Gonzalez, ... Disease markers 35, 945-953, 2013 | 23 | 2013 |
| Prognostic value of perioperative N-terminal pro-B-type natriuretic peptide in noncardiac surgery FK Borges, MV Furtado, APW Rossini, C Bertoluci, VL Gonzalez, ... Arquivos Brasileiros De Cardiologia 100, 561-570, 2013 | 19 | 2013 |
| Revisiting heart failure assessment based on objective measures in NYHA functional classes I and II M Blacher, A Zimerman, PHB Engster, E Grespan, CA Polanczyk, ... Heart 107 (18), 1487-1492, 2021 | 14 | 2021 |
| Rational and design of a randomized, double-blind, multicenter trial to evaluate the safety and tolerability of furosemide withdrawal in stable chronic outpatients with heart … PR da Rosa, LE Rohde, M Doebber, ALP Ribeiro, DP Prado, EG Bertoldi, ... American Heart Journal 194, 125-131, 2017 | 13 | 2017 |
| Prevalence of metabolic syndrome and its association with risk factors in patients with established atherosclerosis disease A Longo, BLP Ribas, SP Orlandi, B Weber, EG Bertoldi, LR Borges, ... Anais da Academia Brasileira de Ciências 92, e20180563, 2020 | 8 | 2020 |
| Contemporary context of drug-eluting stents in Brazil: a cost utility study SF Stella, E Gehling Bertoldi, CA Polanczyk Medical Decision Making 36 (8), 1034-1042, 2016 | 7 | 2016 |
| Fatores de risco cardiovascular e qualidade de vida de acadêmicos de medicina da Universidade Federal de Pelotas F Hickel, BR Fabro, EG Bertoldi Rev. AMRIGS, 186-191, 2015 | 6 | 2015 |
| Consumption of sugar-sweetened beverages in patients with established atherosclerosis disease BLP Ribas, A Longo, FV Dobke, B Weber, EG Bertoldi, LR Borges, ... Ciência & Saúde Coletiva 25, 1499-1506, 2020 | 5 | 2020 |
| Left atrial metastases of poorly differentiated thyroid carcinoma diagnosed by echocardiography and magnetic resonance imaging—case report and review of literature EG Bertoldi, MD Severo, RS Scheffel, M Foppa, MJ de Azevedo, AL Maia Echocardiography 29 (2), E30-E33, 2012 | 5 | 2012 |
| Therapies for type 2 diabetes and coronary artery disease. JH DeVries The New England journal of medicine 361 (14), 1408-9; author reply 1409, 2009 | 5 | 2009 |
| Design of a multifaceted strategy based on automated text messaging in patients with recent heart failure admission LE Rohde, CR Hoffmann Filho, MM Rover, ER Rabelo‐Silva, L Lopez, ... ESC Heart Failure 8 (6), 5523-5530, 2021 | 4 | 2021 |
| Factors associated to serum paraoxonase 1 activity in patients with cardiovascular disease A Longo, GB Veiga, MIS Cousen, C Karpinski, A Schneider, B Weber, ... Archives of endocrinology and metabolism 65, 676-683, 2021 | 4 | 2021 |
Carisi PolanczykProfessor of Medicine, UFRGS, Hospital de Clinicas de Porto Alegre, Hospital Moinhos de VentoEmail confirmado em hcpa.edu.br
